As part of our commitment to patients with unmet needs, we continually work to expand the science behind our therapies, acquire rights to develop new medicines, and partner with researchers, academia and other industry leaders to advance molecules with great potential to create new or better standards of care.

Collaborations with external partners are essentials to our R&D efforts. We constantly seek new partnerships with leading individual experts and research teams within biotechnology, academia, as well as with other pharmaceutical companies.